Fibroblast Activation Protein Inhibitor Theranostics
PET Clinics · 2023
DOI: 10.1016/j.cpet.2023.02.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PET Clinics, 2023. Verfasst von Katharina Lückerath und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstrasse 55, 45147…. Hauptthemen laut MEDLINE: Serine Endopeptidases, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: University Hospital Essen.
Abstract (Originalsprache)
Fibroblast activation protein (FAP)-radioligand therapy might be effective in some patients without being curative. FAP-radioligands deliver ionizing radiation directly to FAP+ cancer-associated fibroblasts and, in some cancers, to FAP+ tumor cells; in addition, they indirectly irradiate FAP- cells in tumor tissue via cross-fire and bystander effects. Here, we discuss the potential to improve FAP-radioligand therapy through interfering with DNA damage repair, immunotherapy, and co-targeting cancer-associated fibroblasts. As the molecular and cellular effects of FAP-radioligands on the tumor and its microenvironment have not been investigated yet, we call for future research to close this gap in knowledge, which prevents the development of more effective FAP-radioligand therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany. Electronic address: katharina.lueckerath@uk-essen.de.
- Division of Solid Tumor Translational Oncology, DKTK and German Cancer Research Center (DKFZ) Partner Side Essen, Hufelandstrasse 15, 45147, Germany; Bridge Institute of Experimental Tumor Therapy, West German Cancer Ce…
- Ahmanson Translational Theranostic Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, 650 Charles E Young Drive S, Los Angeles, CA 90095, USA.
Förderung
- University Hospital Essen
Zitieren
APA
Lückerath, K., Trajkovic-Arsic, M., & Mona, C. E. (2023). Fibroblast Activation Protein Inhibitor Theranostics. PET Clinics. https://doi.org/10.1016/j.cpet.2023.02.006
Vancouver
Lückerath K, Trajkovic-Arsic M, Mona CE. Fibroblast Activation Protein Inhibitor Theranostics. PET Clinics. 2023. doi:10.1016/j.cpet.2023.02.006
BibTeX
@article{Lckerath2023,
author = {Lückerath, Katharina and Trajkovic-Arsic, Marija and Mona, Christine E},
title = {Fibroblast Activation Protein Inhibitor Theranostics},
journal = {PET Clinics},
year = {2023},
doi = {10.1016/j.cpet.2023.02.006}
}
EUVIMED